Jubilant Therapeutics
Mohd Zainuddin is an accomplished professional with extensive experience in drug metabolism and pharmacokinetics (DMPK) within the pharmaceutical industry. Currently serving as the Director at Jubilant Therapeutics Inc since January 2021, Mohd has led preclinical DMPK/Tox initiatives and managed IND submissions and phase 1/2 trials. Prior to this role, Mohd held various positions at Jubilant Life Sciences Ltd., including Associate Director of Drug Metabolism and Pharmacokinetics, and has contributed significantly in different capacities at Jubilant Biosys Limited. Mohd began the career as an Assistant Professor at CSJMU, Kanpur, after completing a PhD in Biochemistry from Aligarh Muslim University. Mohd possesses a strong track record in driving drug discovery projects and optimizing the ADME properties of new chemical entities across multiple therapeutic areas.
This person is not in any teams
This person is not in any offices
Jubilant Therapeutics
2 followers
Jubilant Tx is a patient-focused biopharmaceutical company advancing small molecule modulators to address unmet medical needs in oncology & autoimmune diseases.